Q1 2026 Revenue Up 7% to $711M, Net Income Down 3.6%; Completes $72M Acquisition, Continues Share Repurchase
RVTY sits 22% above its 52-week low of $81.22.
Summary
Revvity reported a 7% revenue increase to $711.1 million for Q1 2026, but net income decreased by 3.6% and gross margins compressed. The company completed a $72 million acquisition, continued its share repurchase program, and is preparing for a €500 million debt maturity in July.
Key Events · Earnings and Guidance · RVTY
-
Q1 2026 Financial Performance
Revenue increased 7% year-over-year to $711.1 million, while net income decreased 3.6% to $40.7 million. Gross margin declined by 200 basis points to 54.5% due to product mix, foreign exchange rates, and tariffs.
-
Strategic Acquisition Completed
Revvity acquired Advanced Chemistry Development Inc. (ACD/Labs) for $72.0 million in cash, plus up to $8.0 million in contingent consideration. This acquisition adds scientific software solutions to the Life Sciences segment.
-
Increased Restructuring Costs and Workforce Reduction
Restructuring and other costs rose to $10.7 million in Q1 2026, up from $3.2 million in the prior year, impacting approximately 2% of the workforce through severance and facility consolidations.
-
Active Share Repurchase Program
The company repurchased $79.0 million of common stock in Q1 2026 under its $1.0 billion program, with $800.5 million remaining authorized as of April 5, 2026. An additional $7.8 million was repurchased subsequent to the quarter end.
Analysis · RVTY · Industrial Applications And Services
This quarterly report provides detailed financial results for Q1 2026, confirming previously announced revenue growth but revealing a slight decline in net income and a 200 basis point drop in gross margin. The company also disclosed a strategic acquisition of Advanced Chemistry Development Inc. for $72 million in cash, alongside increased restructuring costs and a 2% workforce reduction. An active share repurchase program is ongoing, with $800.5 million remaining. Investors should monitor the upcoming maturity of €500 million in senior unsecured notes in July 2026 and the company's plans for repayment.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RVTY was trading at $99.30 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $11.1B. The 52-week trading range was $81.22 to $118.30. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.